JP2023542131A5 - - Google Patents
Info
- Publication number
- JP2023542131A5 JP2023542131A5 JP2023517283A JP2023517283A JP2023542131A5 JP 2023542131 A5 JP2023542131 A5 JP 2023542131A5 JP 2023517283 A JP2023517283 A JP 2023517283A JP 2023517283 A JP2023517283 A JP 2023517283A JP 2023542131 A5 JP2023542131 A5 JP 2023542131A5
- Authority
- JP
- Japan
- Prior art keywords
- cedna vector
- nucleic acid
- acid sequence
- itrs
- adjacent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063078954P | 2020-09-16 | 2020-09-16 | |
| US63/078,954 | 2020-09-16 | ||
| PCT/US2021/050695 WO2022061000A1 (en) | 2020-09-16 | 2021-09-16 | Closed-ended dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542131A JP2023542131A (ja) | 2023-10-05 |
| JP2023542131A5 true JP2023542131A5 (cg-RX-API-DMAC7.html) | 2024-09-25 |
Family
ID=80775707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517283A Pending JP2023542131A (ja) | 2020-09-16 | 2021-09-16 | フェニルアラニンヒドロキシラーゼ(pah)を発現させるための閉端dnaベクター及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240026374A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4214309A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023542131A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230066615A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116507730A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021345187A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3191765A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL301196A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023003019A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022061000A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230079172A (ko) | 2020-10-01 | 2023-06-05 | 젠자임 코포레이션 | 간-유도 유전자 대체 요법에 의한 pku의 치료를 위한 인간 pah 발현 카세트 |
| GB202307239D0 (en) * | 2023-05-15 | 2023-06-28 | Evox Therapeutics Ltd | Gene therapies for Phenylketonuria |
| IL327036A (en) * | 2023-09-19 | 2026-05-01 | Poseida Therapeutics Inc | Compositions and methods for combining viral vectors |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6879486B2 (ja) * | 2015-03-17 | 2021-06-02 | フリーイェ・ユニヴェルシテイト・ブリュッセルVrije Universieit Brussel | Fviiiおよびfix用の最適化された肝臓特異的発現系 |
| IL261524B2 (en) * | 2016-03-03 | 2023-10-01 | Univ Massachusetts | End-capped linear double-stranded DNA for non-viral gene transfer |
| EP3562494A4 (en) * | 2016-12-30 | 2020-08-19 | The Trustees Of The University Of Pennsylvania | GENE THERAPY FOR THE TREATMENT OF PHENYLKETONURIS |
| MX2020001593A (es) * | 2017-08-09 | 2020-07-13 | Bioverativ Therapeutics Inc | Moleculas de acido nucleico y usos de las mismas. |
| CA3075168A1 (en) * | 2017-09-08 | 2019-03-14 | Generation Bio Co. | Modified closed-ended dna (cedna) |
| JP2021505159A (ja) * | 2017-12-06 | 2021-02-18 | ジェネレーション バイオ カンパニー | 修飾型閉端dna(cedna)を使用する遺伝子編集 |
| JP2021511047A (ja) * | 2018-01-19 | 2021-05-06 | ジェネレーション バイオ カンパニー | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
| EP3755803A4 (en) * | 2018-02-22 | 2022-01-19 | Generation Bio Co. | CONTROLLED EXPRESSION OF TRANSGENES USING DNA (CEDNA) VECTORS |
| KR20210008501A (ko) * | 2018-05-09 | 2021-01-22 | 바이오마린 파머수티컬 인크. | 페닐케톤뇨증을 치료하는 방법 |
| CN120349985A (zh) * | 2018-10-12 | 2025-07-22 | 建新公司 | 通过肝导向基因替代疗法治疗严重pku的改良的人pah的产生 |
| CA3129321A1 (en) * | 2019-02-15 | 2020-08-20 | Generation Bio Co. | Modulation of rep protein activity in closed-ended dna (cedna) production |
| US12415002B2 (en) * | 2019-03-13 | 2025-09-16 | Generation Bio Co. | Non-viral DNA vectors and uses thereof for expressing phenylalanine hydroxylase (PAH) therapeutics |
| BR112021024124A2 (pt) * | 2019-05-31 | 2022-01-11 | American Gene Tech Int Inc | Expressão otimizada de fenilalanina hidroxilase |
-
2021
- 2021-09-16 MX MX2023003019A patent/MX2023003019A/es unknown
- 2021-09-16 CA CA3191765A patent/CA3191765A1/en active Pending
- 2021-09-16 IL IL301196A patent/IL301196A/en unknown
- 2021-09-16 EP EP21870225.6A patent/EP4214309A4/en active Pending
- 2021-09-16 AU AU2021345187A patent/AU2021345187A1/en active Pending
- 2021-09-16 WO PCT/US2021/050695 patent/WO2022061000A1/en not_active Ceased
- 2021-09-16 US US18/025,926 patent/US20240026374A1/en active Pending
- 2021-09-16 JP JP2023517283A patent/JP2023542131A/ja active Pending
- 2021-09-16 CN CN202180076781.0A patent/CN116507730A/zh active Pending
- 2021-09-16 KR KR1020237012572A patent/KR20230066615A/ko active Pending